Strike freezes J&J's Belgian ops

Belgian employees upset about Johnson & Johnson's restructuring (and the subsequent layoffs) have gone on strike. The company's Belgian unit, Janssen Pharmaceuticals, has been shut down by the strikers, who are blocking entrances at all four of its facilities.

Workers are striking to protest a severance package offered to the 500-plus employees slated to be laid off. The workers rejected the offer Thursday, and their trade union then initiated the strike this morning. A company spokesperson said no negotiations are now taking place, and there's no word when talks might resume.

- read the report from

Related Articles:
J&J reorg anoints growth czar. Report
&J restructures pharma unit, laying off workers. Report
J&J makes big cuts at Alza and Scios. Report

Suggested Articles

Horizon Therapeutics has notched an FDA approval for its rare eye disease med Tepezza (teprotumumab), a possible blockbuster drug in the making.

Eli Lilly has a pipeline stuffed with a host of assets and has decided it needs a new injectable drug and device plant to manufacture some of them.

After Clovis’ Rubraca snagged an FDA boost in prostate cancer last week, AZ and Merck’s rival Lynparza has matched it with a boost of its own.